+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

France Animal Vaccine Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: France
  • Orion Market Research Private Limited
  • ID: 4969036
France Animal Vaccine Market Size, Share & Trends Analysis Report, By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) and Forecast, 2019-2025.

France animal vaccine market is estimated to grow at a CAGR of around 5.6% during the forecast period. France is well known for the high yielding dairy goats and a major producer of dairy products, including cheese. Additionally, France is also a substantial producer of meat across the region. France is breeding a few dairy breeds of goats including Saanen, Toggenburg, Alpine, and Anglo-Nubian, which are widespread and are frequently found in commercial herds throughout the country. Exotic breeds of the goat are increasing proportionally owing to the emerging goat exports from France. As the breeding of goats is increasing year-over-year, consumption of animal vaccines is also growing in the country. Vaccines are becoming an integral part of the animal husbandry across the country due to stringent government regulations imposed by the EU, which in turn, is leading to propel the market growth.

Key players in the France animal vaccine market include Zoetis, Inc., Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, and Vetoquinol S. A. These players are adopting crucial strategies, such as mergers and acquisitions, product launches, geographical expansion, and partnerships and collaborations to maintain their competitiveness and increase their market share. For instance, in September 2019, Boehringer Ingelheim declared that it is developing one of the major biotechnology manufacturing sites for veterinary vaccines in Europe, setting up on pioneering expertise of France in veterinary public health.

This investment of over $224 million will significantly enhance manufacturing capacities for antigens and vaccines to fight against highly contagious diseases. This will enable to offer the means to fight against epidemics of diseases among animals, including bluetongue and foot-and-mouth disease. Through this investment, the Lyon metropolitan area will reinforce its position in the European vaccine valley. With this expansion, the company will be able to supply millions of doses in a few days from Lyon for ring vaccination in affected areas which will support to stop the disease progression.

Research Methodology

The market study of the France animal vaccine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for pharmaceuticals companies, veterinary companies, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation
  • France Animal Vaccine Market Research and Analysis, By Type
  • France Animal Vaccine Market Research and Analysis, By Technology

The Report Covers
  • Comprehensive research methodology of the France animal vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regulations and other government policies impacting the France animal vaccine market.
  • Insights about market determinants which are stimulating the France animal vaccine market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. France Animal Vaccine Market by Type
5.1.1. Porcine Vaccines
5.1.2. Poultry Vaccines
5.1.3. Livestock Vaccines
5.1.4. Aquaculture Vaccines
5.1.5. Companion Animal Vaccines
5.1.6. Other Animal Vaccines
5.2. France Animal Vaccine Market by Technology
5.2.1. Live Attenuated Vaccine
5.2.2. Killed/Inactive Vaccine
5.2.3. Recombinant Vaccine
5.2.4. Vectored Vaccine
5.2.5. Subunit Vaccine
5.2.6. DNA Vaccine
5.2.7. Chimeric Vaccine
5.2.8. Others
6. Company Profiles
6.1. Boehringer Ingelheim GmbH
6.2. Ceva Santé Animale
6.3. Elanco
6.4. Heska Corp.
6.5. Merck & Co., Inc.
6.6. Neogen Corp.
6.8. Vetoquinol S.A.
6.9. Virbac SA
6.10. Zoetis, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Elanco
  • Heska Corp.
  • Merck & Co., Inc.
  • Neogen Corp.
  • Vetoquinol S.A.
  • Virbac SA
  • Zoetis, Inc.